ASSOCIATION BETWEEN OBESITY AND HYPOTHYROIDISM: A COMPREHENSIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6534Keywords:
Obesity, Hypothyroidism, Subclinical Hypothyroidism, Thyroid FunctionAbstract
Obesity and hypothyroidism are among the most prevalent chronic disorders worldwide and frequently coexist in clinical practice. Although hypothyroidism has traditionally been regarded as a contributing factor to weight gain because of its effects on basal metabolic rate and energy expenditure, accumulating evidence suggests that obesity itself may substantially influence thyroid function through endocrine, metabolic, and inflammatory mechanisms. This comprehensive review summarizes current evidence regarding the association between obesity and hypothyroidism, focusing on epidemiological findings, pathophysiological mechanisms, thyroid autoimmunity, metabolic phenotypes, pediatric and adult populations, and therapeutic implications. Evidence from systematic reviews, longitudinal cohort studies, Mendelian randomization analyses, and observational investigations indicates that obesity is associated with an increased prevalence of both overt and subclinical hypothyroidism. Adipose tissue-derived mediators, particularly leptin and pro-inflammatory cytokines, appear to influence the hypothalamic–pituitary–thyroid axis, alter peripheral thyroid hormone metabolism, and promote autoimmune thyroid disease. However, mild elevations of thyroid-stimulating hormone observed in many obese individuals, especially children, often represent adaptive physiological responses rather than permanent thyroid dysfunction and frequently normalize following weight reduction. Current evidence further suggests that improving metabolic health and reducing excess body weight have greater effects on thyroid function than thyroid hormone replacement alone in patients without overt hypothyroidism. Overall, the available literature supports a bidirectional but predominantly obesity-driven relationship between obesity and thyroid dysfunction. Understanding these mechanisms may improve diagnostic accuracy, reduce unnecessary pharmacological treatment, and facilitate individualized management strategies for patients presenting with both conditions.
References
Akici, N., Onal, Z. E., Gürbüz, T., Sağ, C., & Kilinç, S. (2020). Atherogenic indices in the assessment of cardiovascular disease risk in children with obesity and subclinical hypothyroidism. Acta Endocrinologica (Bucharest), 16(3), 334–338.
Bakos, B., Solymosi, T., Szili, B., Vincze, Á., Mészáros, Sz., Stempler, M., et al. (2025). Psychological factors and obesity, not thyroid biomarkers, predict thyroid-dependent quality of life in treated hypothyroidism: A cross-sectional study. BMC Endocrine Disorders, 25, 136.
Bambini, F., Gatta, E., D'Alessio, R., Dondi, F., Pignata, G., Pirola, I., et al. (2023). Thyroid disease and autoimmunity in obese patients: A narrative review. Endokrynologia Polska, 74(6), 576–590.
Biondi, B. (2024). Subclinical hypothyroidism in patients with obesity and metabolic syndrome: A narrative review. Nutrients, 16(1), 87.
Dulloo, A. G. (2025). Adaptive thermogenesis driving catch-up fat during weight regain: A role for skeletal muscle hypothyroidism and a risk for sarcopenic obesity. Reviews in Endocrine and Metabolic Disorders, 26, 871–888.
El Amrousy, D., El-Afify, D., & Salah, S. (2022). Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity. BMC Pediatrics, 22, 245.
Galofré, J. C., Díez, J. J., Attanasio, R., Nagy, E. V., Negro, R., Papini, E., et al. (2025). Treatment of obesity with thyroid hormones in Europe: Data from the THESIS Collaboration. Journal of Endocrinological Investigation, 48, 201–212.
Gokkaya, N., & Aydin, K. (2024). Efficacy of levothyroxine monotherapy in achieving clinical euthyroidism and its impact on weight loss in women with hypothyroidism and obesity. Scientific Reports, 14, Article 27822.
Tersander, B., Olsson, R., Aydin, B. K., Stenlid, R., Ciba, I., & Manell, H. (2025). Obesity-related subclinical hypothyroidism in childhood: Elevated triglycerides but not basal metabolic rate. Pediatric Research, 98, 182–187.
Wang, Y., Lin, H., Li, Q., Guan, L., Zhao, M., Zhong, F., et al. (2021). Association between different obesity phenotypes and hypothyroidism: A study based on a longitudinal health management cohort. Endocrine, 72, 688–698.
Wojciechowska, M., Wiśniewski, O. W., Pruszyńska-Oszmałek, E., Krauss, H., Sassek, M., Leciejewska, N., et al. (2022). Effect of obesity and hypothyroidism on hepcidin concentration in pregnancy—A pilot study using maternal and umbilical cord blood at delivery day. Journal of Physiology and Pharmacology, 73(5), 605–612.
Yan, Y., Xu, M., Wu, M., Wang, X., Li, F., Zhang, J., et al. (2022). Obesity is associated with subclinical hypothyroidism in the presence of thyroid autoantibodies: A cross-sectional study. BMC Endocrine Disorders, 22, 94.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Bianka Błaszkiewicz, Katarzyna Marut, Ksenia Oksana Kobelak, Iga Borejszo, Małgorzata Lubowiecka, Joanna Marczak, Agata Leszek, Natalia Moskwa, Zuzanna Lecyk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
